Kuopio

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• GlaxoSmithKline2 trials

Running trials

• Recruiting

  A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

  NCT06885034· Phase 1/2· GlaxoSmithKline· Source

  Contact: Okko Kääriäinen (principal investigator)

• Active, not recruiting

  A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

  NCT06472076· Phase 3· GlaxoSmithKline· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Pancreatic cancer1 recruiting